1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Poliomyelitis Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Medicine 1.2.3 Surgery 1.2.4 Service 1.2.5 Other 1.3 Market by Application 1.3.1 Global Poliomyelitis Therapeutics Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Hospital 1.3.3 Clinic 1.3.4 Other 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Poliomyelitis Therapeutics Market Perspective (2016-2027) 2.2 Poliomyelitis Therapeutics Growth Trends by Regions 2.2.1 Poliomyelitis Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Poliomyelitis Therapeutics Historic Market Share by Regions (2016-2021) 2.2.3 Poliomyelitis Therapeutics Forecasted Market Size by Regions (2022-2027) 2.3 Poliomyelitis Therapeutics Industry Dynamic 2.3.1 Poliomyelitis Therapeutics Market Trends 2.3.2 Poliomyelitis Therapeutics Market Drivers 2.3.3 Poliomyelitis Therapeutics Market Challenges 2.3.4 Poliomyelitis Therapeutics Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Poliomyelitis Therapeutics Players by Revenue 3.1.1 Global Top Poliomyelitis Therapeutics Players by Revenue (2016-2021) 3.1.2 Global Poliomyelitis Therapeutics Revenue Market Share by Players (2016-2021) 3.2 Global Poliomyelitis Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Poliomyelitis Therapeutics Revenue 3.4 Global Poliomyelitis Therapeutics Market Concentration Ratio 3.4.1 Global Poliomyelitis Therapeutics Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Poliomyelitis Therapeutics Revenue in 2020 3.5 Poliomyelitis Therapeutics Key Players Head office and Area Served 3.6 Key Players Poliomyelitis Therapeutics Product Solution and Service 3.7 Date of Enter into Poliomyelitis Therapeutics Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Poliomyelitis Therapeutics Breakdown Data by Type 4.1 Global Poliomyelitis Therapeutics Historic Market Size by Type (2016-2021) 4.2 Global Poliomyelitis Therapeutics Forecasted Market Size by Type (2022-2027) 5 Poliomyelitis Therapeutics Breakdown Data by Application 5.1 Global Poliomyelitis Therapeutics Historic Market Size by Application (2016-2021) 5.2 Global Poliomyelitis Therapeutics Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Poliomyelitis Therapeutics Market Size (2016-2027) 6.2 North America Poliomyelitis Therapeutics Market Size by Type 6.2.1 North America Poliomyelitis Therapeutics Market Size by Type (2016-2021) 6.2.2 North America Poliomyelitis Therapeutics Market Size by Type (2022-2027) 6.2.3 North America Poliomyelitis Therapeutics Market Size by Type (2016-2027) 6.3 North America Poliomyelitis Therapeutics Market Size by Application 6.3.1 North America Poliomyelitis Therapeutics Market Size by Application (2016-2021) 6.3.2 North America Poliomyelitis Therapeutics Market Size by Application (2022-2027) 6.3.3 North America Poliomyelitis Therapeutics Market Size by Application (2016-2027) 6.4 North America Poliomyelitis Therapeutics Market Size by Country 6.4.1 North America Poliomyelitis Therapeutics Market Size by Country (2016-2021) 6.4.2 North America Poliomyelitis Therapeutics Market Size by Country (2022-2027) 6.4.3 United States 6.4.4 Canada 7 Europe 7.1 Europe Poliomyelitis Therapeutics Market Size (2016-2027) 7.2 Europe Poliomyelitis Therapeutics Market Size by Type 7.2.1 Europe Poliomyelitis Therapeutics Market Size by Type (2016-2021) 7.2.2 Europe Poliomyelitis Therapeutics Market Size by Type (2022-2027) 7.2.3 Europe Poliomyelitis Therapeutics Market Size by Type (2016-2027) 7.3 Europe Poliomyelitis Therapeutics Market Size by Application 7.3.1 Europe Poliomyelitis Therapeutics Market Size by Application (2016-2021) 7.3.2 Europe Poliomyelitis Therapeutics Market Size by Application (2022-2027) 7.3.3 Europe Poliomyelitis Therapeutics Market Size by Application (2016-2027) 7.4 Europe Poliomyelitis Therapeutics Market Size by Country 7.4.1 Europe Poliomyelitis Therapeutics Market Size by Country (2016-2021) 7.4.2 Europe Poliomyelitis Therapeutics Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Poliomyelitis Therapeutics Market Size (2016-2027) 8.2 Asia-Pacific Poliomyelitis Therapeutics Market Size by Type 8.2.1 Asia-Pacific Poliomyelitis Therapeutics Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Poliomyelitis Therapeutics Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Poliomyelitis Therapeutics Market Size by Type (2016-2027) 8.3 Asia-Pacific Poliomyelitis Therapeutics Market Size by Application 8.3.1 Asia-Pacific Poliomyelitis Therapeutics Market Size by Application (2016-2021) 8.3.2 Asia-Pacific Poliomyelitis Therapeutics Market Size by Application (2022-2027) 8.3.3 Asia-Pacific Poliomyelitis Therapeutics Market Size by Application (2016-2027) 8.4 Asia-Pacific Poliomyelitis Therapeutics Market Size by Region 8.4.1 Asia-Pacific Poliomyelitis Therapeutics Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Poliomyelitis Therapeutics Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Poliomyelitis Therapeutics Market Size (2016-2027) 9.2 Latin America Poliomyelitis Therapeutics Market Size by Type 9.2.1 Latin America Poliomyelitis Therapeutics Market Size by Type (2016-2021) 9.2.2 Latin America Poliomyelitis Therapeutics Market Size by Type (2022-2027) 9.2.3 Latin America Poliomyelitis Therapeutics Market Size by Type (2016-2027) 9.3 Latin America Poliomyelitis Therapeutics Market Size by Application 9.3.1 Latin America Poliomyelitis Therapeutics Market Size by Application (2016-2021) 9.3.2 Latin America Poliomyelitis Therapeutics Market Size by Application (2022-2027) 9.3.3 Latin America Poliomyelitis Therapeutics Market Size by Application (2016-2027) 9.4 Latin America Poliomyelitis Therapeutics Market Size by Country 9.4.1 Latin America Poliomyelitis Therapeutics Market Size by Country (2016-2021) 9.4.2 Latin America Poliomyelitis Therapeutics Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Poliomyelitis Therapeutics Market Size (2016-2027) 10.2 Middle East & Africa Poliomyelitis Therapeutics Market Size by Type 10.2.1 Middle East & Africa Poliomyelitis Therapeutics Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Poliomyelitis Therapeutics Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Poliomyelitis Therapeutics Market Size by Type (2016-2027) 10.3 Middle East & Africa Poliomyelitis Therapeutics Market Size by Application 10.3.1 Middle East & Africa Poliomyelitis Therapeutics Market Size by Application (2016-2021) 10.3.2 Middle East & Africa Poliomyelitis Therapeutics Market Size by Application (2022-2027) 10.3.3 Middle East & Africa Poliomyelitis Therapeutics Market Size by Application (2016-2027) 10.4 Middle East & Africa Poliomyelitis Therapeutics Market Size by Country 10.4.1 Middle East & Africa Poliomyelitis Therapeutics Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Poliomyelitis Therapeutics Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Sanofi 11.1.1 Sanofi Company Details 11.1.2 Sanofi Business Overview 11.1.3 Sanofi Poliomyelitis Therapeutics Introduction 11.1.4 Sanofi Revenue in Poliomyelitis Therapeutics Business (2016-2021) 11.1.5 Sanofi Recent Development 11.2 GSK 11.2.1 GSK Company Details 11.2.2 GSK Business Overview 11.2.3 GSK Poliomyelitis Therapeutics Introduction 11.2.4 GSK Revenue in Poliomyelitis Therapeutics Business (2016-2021) 11.2.5 GSK Recent Development 11.3 Bibcol 11.3.1 Bibcol Company Details 11.3.2 Bibcol Business Overview 11.3.3 Bibcol Poliomyelitis Therapeutics Introduction 11.3.4 Bibcol Revenue in Poliomyelitis Therapeutics Business (2016-2021) 11.3.5 Bibcol Recent Development 11.4 Serum Institute 11.4.1 Serum Institute Company Details 11.4.2 Serum Institute Business Overview 11.4.3 Serum Institute Poliomyelitis Therapeutics Introduction 11.4.4 Serum Institute Revenue in Poliomyelitis Therapeutics Business (2016-2021) 11.4.5 Serum Institute Recent Development 11.5 Tiantan Biological 11.5.1 Tiantan Biological Company Details 11.5.2 Tiantan Biological Business Overview 11.5.3 Tiantan Biological Poliomyelitis Therapeutics Introduction 11.5.4 Tiantan Biological Revenue in Poliomyelitis Therapeutics Business (2016-2021) 11.5.5 Tiantan Biological Recent Development 11.6 IMBCA 11.6.1 IMBCA Company Details 11.6.2 IMBCA Business Overview 11.6.3 IMBCA Poliomyelitis Therapeutics Introduction 11.6.4 IMBCA Revenue in Poliomyelitis Therapeutics Business (2016-2021) 11.6.5 IMBCA Recent Development 11.7 Panacea Biotec 11.7.1 Panacea Biotec Company Details 11.7.2 Panacea Biotec Business Overview 11.7.3 Panacea Biotec Poliomyelitis Therapeutics Introduction 11.7.4 Panacea Biotec Revenue in Poliomyelitis Therapeutics Business (2016-2021) 11.7.5 Panacea Biotec Recent Development 11.8 Bio-Med 11.8.1 Bio-Med Company Details 11.8.2 Bio-Med Business Overview 11.8.3 Bio-Med Poliomyelitis Therapeutics Introduction 11.8.4 Bio-Med Revenue in Poliomyelitis Therapeutics Business (2016-2021) 11.8.5 Bio-Med Recent Development 11.9 Halfkin Bio-Pharmaceuticals 11.9.1 Halfkin Bio-Pharmaceuticals Company Details 11.9.2 Halfkin Bio-Pharmaceuticals Business Overview 11.9.3 Halfkin Bio-Pharmaceuticals Poliomyelitis Therapeutics Introduction 11.9.4 Halfkin Bio-Pharmaceuticals Revenue in Poliomyelitis Therapeutics Business (2016-2021) 11.9.5 Halfkin Bio-Pharmaceuticals Recent Development 11.10 Merck 11.10.1 Merck Company Details 11.10.2 Merck Business Overview 11.10.3 Merck Poliomyelitis Therapeutics Introduction 11.10.4 Merck Revenue in Poliomyelitis Therapeutics Business (2016-2021) 11.10.5 Merck Recent Development 11.11 CSL 11.11.1 CSL Company Details 11.11.2 CSL Business Overview 11.11.3 CSL Poliomyelitis Therapeutics Introduction 11.11.4 CSL Revenue in Poliomyelitis Therapeutics Business (2016-2021) 11.11.5 CSL Recent Development 11.12 Astellas Pharma 11.12.1 Astellas Pharma Company Details 11.12.2 Astellas Pharma Business Overview 11.12.3 Astellas Pharma Poliomyelitis Therapeutics Introduction 11.12.4 Astellas Pharma Revenue in Poliomyelitis Therapeutics Business (2016-2021) 11.12.5 Astellas Pharma Recent Development 11.13 Emergent BioSolutions 11.13.1 Emergent BioSolutions Company Details 11.13.2 Emergent BioSolutions Business Overview 11.13.3 Emergent BioSolutions Poliomyelitis Therapeutics Introduction 11.13.4 Emergent BioSolutions Revenue in Poliomyelitis Therapeutics Business (2016-2021) 11.13.5 Emergent BioSolutions Recent Development 11.14 Johnson & Johnson 11.14.1 Johnson & Johnson Company Details 11.14.2 Johnson & Johnson Business Overview 11.14.3 Johnson & Johnson Poliomyelitis Therapeutics Introduction 11.14.4 Johnson & Johnson Revenue in Poliomyelitis Therapeutics Business (2016-2021) 11.14.5 Johnson & Johnson Recent Development 11.15 Pfizer 11.15.1 Pfizer Company Details 11.15.2 Pfizer Business Overview 11.15.3 Pfizer Poliomyelitis Therapeutics Introduction 11.15.4 Pfizer Revenue in Poliomyelitis Therapeutics Business (2016-2021) 11.15.5 Pfizer Recent Development 11.16 MedImmune 11.16.1 MedImmune Company Details 11.16.2 MedImmune Business Overview 11.16.3 MedImmune Poliomyelitis Therapeutics Introduction 11.16.4 MedImmune Revenue in Poliomyelitis Therapeutics Business (2016-2021) 11.16.5 MedImmune Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Poliomyelitis Therapeutics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of Medicine Table 3. Key Players of Surgery Table 4. Key Players of Service Table 5. Key Players of Other Table 6. Global Poliomyelitis Therapeutics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 7. Global Poliomyelitis Therapeutics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 8. Global Poliomyelitis Therapeutics Market Size by Regions (2016-2021) & (US$ Million) Table 9. Global Poliomyelitis Therapeutics Market Share by Regions (2016-2021) Table 10. Global Poliomyelitis Therapeutics Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 11. Global Poliomyelitis Therapeutics Market Share by Regions (2022-2027) Table 12. Poliomyelitis Therapeutics Market Trends Table 13. Poliomyelitis Therapeutics Market Drivers Table 14. Poliomyelitis Therapeutics Market Challenges Table 15. Poliomyelitis Therapeutics Market Restraints Table 16. Global Poliomyelitis Therapeutics Revenue by Players (2016-2021) & (US$ Million) Table 17. Global Poliomyelitis Therapeutics Market Share by Players (2016-2021) Table 18. Global Top Poliomyelitis Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Poliomyelitis Therapeutics as of 2020) Table 19. Ranking of Global Top Poliomyelitis Therapeutics Companies by Revenue (US$ Million) in 2020 Table 20. Global 5 Largest Players Market Share by Poliomyelitis Therapeutics Revenue (CR5 and HHI) & (2016-2021) Table 21. Key Players Headquarters and Area Served Table 22. Key Players Poliomyelitis Therapeutics Product Solution and Service Table 23. Date of Enter into Poliomyelitis Therapeutics Market Table 24. Mergers & Acquisitions, Expansion Plans Table 25. Global Poliomyelitis Therapeutics Market Size by Type (2016-2021) (US$ Million) Table 26. Global Poliomyelitis Therapeutics Revenue Market Share by Type (2016-2021) Table 27. Global Poliomyelitis Therapeutics Forecasted Market Size by Type (2022-2027) (US$ Million) Table 28. Global Poliomyelitis Therapeutics Revenue Market Share by Type (2022-2027) & (US$ Million) Table 29. Global Poliomyelitis Therapeutics Market Size Share by Application (2016-2021) & (US$ Million) Table 30. Global Poliomyelitis Therapeutics Revenue Market Share by Application (2016-2021) Table 31. Global Poliomyelitis Therapeutics Forecasted Market Size by Application (2022-2027) (US$ Million) Table 32. Global Poliomyelitis Therapeutics Revenue Market Share by Application (2022-2027) & (US$ Million) Table 33. North America Poliomyelitis Therapeutics Market Size by Type (2016-2021) (US$ Million) Table 34. North America Poliomyelitis Therapeutics Market Size by Type (2022-2027) & (US$ Million) Table 35. North America Poliomyelitis Therapeutics Market Size by Application (2016-2021) (US$ Million) Table 36. North America Poliomyelitis Therapeutics Market Size by Application (2022-2027) & (US$ Million) Table 37. North America Poliomyelitis Therapeutics Market Size by Country (2016-2021) & (US$ Million) Table 38. North America Poliomyelitis Therapeutics Market Size by Country (2022-2027) & (US$ Million) Table 39. Europe Poliomyelitis Therapeutics Market Size by Type (2016-2021) (US$ Million) Table 40. Europe Poliomyelitis Therapeutics Market Size by Type (2022-2027) & (US$ Million) Table 41. Europe Poliomyelitis Therapeutics Market Size by Application (2016-2021) (US$ Million) Table 42. Europe Poliomyelitis Therapeutics Market Size by Application (2022-2027) & (US$ Million) Table 43. Europe Poliomyelitis Therapeutics Market Size by Country (2016-2021) & (US$ Million) Table 44. Europe Poliomyelitis Therapeutics Market Size by Country (2022-2027) & (US$ Million) Table 45. Asia-Pacific Poliomyelitis Therapeutics Market Size by Type (2016-2021) (US$ Million) Table 46. Asia-Pacific Poliomyelitis Therapeutics Market Size by Type (2022-2027) & (US$ Million) Table 47. Asia-Pacific Poliomyelitis Therapeutics Market Size by Application (2016-2021) (US$ Million) Table 48. Asia-Pacific Poliomyelitis Therapeutics Market Size by Application (2022-2027) & (US$ Million) Table 49. Asia-Pacific Poliomyelitis Therapeutics Market Size by Region (2016-2021) & (US$ Million) Table 50. Asia-Pacific Poliomyelitis Therapeutics Market Size by Region (2022-2027) & (US$ Million) Table 51. Latin America Poliomyelitis Therapeutics Market Size by Type (2016-2021) (US$ Million) Table 52. Latin America Poliomyelitis Therapeutics Market Size by Type (2022-2027) & (US$ Million) Table 53. Latin America Poliomyelitis Therapeutics Market Size by Application (2016-2021) (US$ Million) Table 54. Latin America Poliomyelitis Therapeutics Market Size by Application (2022-2027) & (US$ Million) Table 55. Latin America Poliomyelitis Therapeutics Market Size by Country (2016-2021) & (US$ Million) Table 56. Latin America Poliomyelitis Therapeutics Market Size by Country (2022-2027) & (US$ Million) Table 57. Middle East & Africa Poliomyelitis Therapeutics Market Size by Type (2016-2021) (US$ Million) Table 58. Middle East & Africa Poliomyelitis Therapeutics Market Size by Type (2022-2027) & (US$ Million) Table 59. Middle East & Africa Poliomyelitis Therapeutics Market Size by Application (2016-2021) (US$ Million) Table 60. Middle East & Africa Poliomyelitis Therapeutics Market Size by Application (2022-2027) & (US$ Million) Table 61. Middle East & Africa Poliomyelitis Therapeutics Market Size by Country (2016-2021) & (US$ Million) Table 62. Middle East & Africa Poliomyelitis Therapeutics Market Size by Country (2022-2027) & (US$ Million) Table 63. Sanofi Company Details Table 64. Sanofi Business Overview Table 65. Sanofi Poliomyelitis Therapeutics Product Table 66. Sanofi Revenue in Poliomyelitis Therapeutics Business (2016-2021) & (US$ Million) Table 67. Sanofi Recent Development Table 68. GSK Company Details Table 69. GSK Business Overview Table 70. GSK Poliomyelitis Therapeutics Product Table 71. GSK Revenue in Poliomyelitis Therapeutics Business (2016-2021) & (US$ Million) Table 72. GSK Recent Development Table 73. Bibcol Company Details Table 74. Bibcol Business Overview Table 75. Bibcol Poliomyelitis Therapeutics Product Table 76. Bibcol Revenue in Poliomyelitis Therapeutics Business (2016-2021) & (US$ Million) Table 77. Bibcol Recent Development Table 78. Serum Institute Company Details Table 79. Serum Institute Business Overview Table 80. Serum Institute Poliomyelitis Therapeutics Product Table 81. Serum Institute Revenue in Poliomyelitis Therapeutics Business (2016-2021) & (US$ Million) Table 82. Serum Institute Recent Development Table 83. Tiantan Biological Company Details Table 84. Tiantan Biological Business Overview Table 85. Tiantan Biological Poliomyelitis Therapeutics Product Table 86. Tiantan Biological Revenue in Poliomyelitis Therapeutics Business (2016-2021) & (US$ Million) Table 87. Tiantan Biological Recent Development Table 88. IMBCA Company Details Table 89. IMBCA Business Overview Table 90. IMBCA Poliomyelitis Therapeutics Product Table 91. IMBCA Revenue in Poliomyelitis Therapeutics Business (2016-2021) & (US$ Million) Table 92. IMBCA Recent Development Table 93. Panacea Biotec Company Details Table 94. Panacea Biotec Business Overview Table 95. Panacea Biotec Poliomyelitis Therapeutics Product Table 96. Panacea Biotec Revenue in Poliomyelitis Therapeutics Business (2016-2021) & (US$ Million) Table 97. Panacea Biotec Recent Development Table 98. Bio-Med Company Details Table 99. Bio-Med Business Overview Table 100. Bio-Med Revenue in Poliomyelitis Therapeutics Business (2016-2021) & (US$ Million) Table 101. Bio-Med Recent Development Table 102. Halfkin Bio-Pharmaceuticals Company Details Table 103. Halfkin Bio-Pharmaceuticals Business Overview Table 104. Halfkin Bio-Pharmaceuticals Poliomyelitis Therapeutics Product Table 105. Halfkin Bio-Pharmaceuticals Revenue in Poliomyelitis Therapeutics Business (2016-2021) & (US$ Million) Table 106. Halfkin Bio-Pharmaceuticals Recent Development Table 107. Merck Company Details Table 108. Merck Business Overview Table 109. Merck Poliomyelitis Therapeutics Product Table 110. Merck Revenue in Poliomyelitis Therapeutics Business (2016-2021) & (US$ Million) Table 111. Merck Recent Development Table 112. CSL Company Details Table 113. CSL Business Overview Table 114. CSL Poliomyelitis Therapeutics Product Table 115. CSL Revenue in Poliomyelitis Therapeutics Business (2016-2021) & (US$ Million) Table 116. CSL Recent Development Table 117. Astellas Pharma Company Details Table 118. Astellas Pharma Business Overview Table 119. Astellas Pharma Poliomyelitis Therapeutics Product Table 120. Astellas Pharma Revenue in Poliomyelitis Therapeutics Business (2016-2021) & (US$ Million) Table 121. Astellas Pharma Recent Development Table 122. Emergent BioSolutions Company Details Table 123. Emergent BioSolutions Business Overview Table 124. Emergent BioSolutions Poliomyelitis Therapeutics Product Table 125. Emergent BioSolutions Revenue in Poliomyelitis Therapeutics Business (2016-2021) & (US$ Million) Table 126. Emergent BioSolutions Recent Development Table 127. Johnson & Johnson Company Details Table 128. Johnson & Johnson Business Overview Table 129. Johnson & Johnson Poliomyelitis Therapeutics Product Table 130. Johnson & Johnson Revenue in Poliomyelitis Therapeutics Business (2016-2021) & (US$ Million) Table 131. Johnson & Johnson Recent Development Table 132. Pfizer Company Details Table 133. Pfizer Business Overview Table 134. Pfizer Poliomyelitis Therapeutics Product Table 135. Pfizer Revenue in Poliomyelitis Therapeutics Business (2016-2021) & (US$ Million) Table 136. Pfizer Recent Development Table 137. MedImmune Company Details Table 138. MedImmune Business Overview Table 139. MedImmune Poliomyelitis Therapeutics Product Table 140. MedImmune Revenue in Poliomyelitis Therapeutics Business (2016-2021) & (US$ Million) Table 141. MedImmune Recent Development Table 142. Research Programs/Design for This Report Table 143. Key Data Information from Secondary Sources Table 144. Key Data Information from Primary Sources List of Figures Figure 1. Global Poliomyelitis Therapeutics Market Share by Type: 2020 VS 2027 Figure 2. Medicine Features Figure 3. Surgery Features Figure 4. Service Features Figure 5. Other Features Figure 6. Global Poliomyelitis Therapeutics Market Share by Application: 2020 VS 2027 Figure 7. Hospital Case Studies Figure 8. Clinic Case Studies Figure 9. Other Case Studies Figure 10. Poliomyelitis Therapeutics Report Years Considered Figure 11. Global Poliomyelitis Therapeutics Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 12. Global Poliomyelitis Therapeutics Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 13. Global Poliomyelitis Therapeutics Market Share by Regions: 2020 VS 2027 Figure 14. Global Poliomyelitis Therapeutics Market Share by Regions (2022-2027) Figure 15. Global Poliomyelitis Therapeutics Market Share by Players in 2020 Figure 16. Global Top Poliomyelitis Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Poliomyelitis Therapeutics as of 2020 Figure 17. The Top 10 and 5 Players Market Share by Poliomyelitis Therapeutics Revenue in 2020 Figure 18. Global Poliomyelitis Therapeutics Revenue Market Share by Type (2016-2021) Figure 19. Global Poliomyelitis Therapeutics Revenue Market Share by Type (2022-2027) Figure 20. North America Poliomyelitis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 21. North America Poliomyelitis Therapeutics Market Share by Type (2016-2027) Figure 22. North America Poliomyelitis Therapeutics Market Share by Application (2016-2027) Figure 23. North America Poliomyelitis Therapeutics Market Share by Country (2016-2027) Figure 24. United States Poliomyelitis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 25. Canada Poliomyelitis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 26. Europe Poliomyelitis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 27. Europe Poliomyelitis Therapeutics Market Share by Type (2016-2027) Figure 28. Europe Poliomyelitis Therapeutics Market Share by Application (2016-2027) Figure 29. Europe Poliomyelitis Therapeutics Market Share by Country (2016-2027) Figure 30. Germany Poliomyelitis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 31. France Poliomyelitis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 32. U.K. Poliomyelitis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 33. Italy Poliomyelitis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. Russia Poliomyelitis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 35. Nordic Poliomyelitis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 36. Asia-Pacific Poliomyelitis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 37. Asia-Pacific Poliomyelitis Therapeutics Market Share by Type (2016-2027) Figure 38. Asia-Pacific Poliomyelitis Therapeutics Market Share by Application (2016-2027) Figure 39. Asia-Pacific Poliomyelitis Therapeutics Market Share by Region (2016-2027) Figure 40. China Poliomyelitis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 41. Japan Poliomyelitis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 42. South Korea Poliomyelitis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 43. Southeast Asia Poliomyelitis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. India Poliomyelitis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 45. Australia Poliomyelitis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 46. Latin America Poliomyelitis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 47. Latin America Poliomyelitis Therapeutics Market Share by Type (2016-2027) Figure 48. Latin America Poliomyelitis Therapeutics Market Share by Application (2016-2027) Figure 49. Latin America Poliomyelitis Therapeutics Market Share by Country (2016-2027) Figure 50. Mexico Poliomyelitis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 51. Brazil Poliomyelitis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 52. Middle East & Africa Poliomyelitis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 53. Middle East & Africa Poliomyelitis Therapeutics Market Share by Type (2016-2027) Figure 54. Middle East & Africa Poliomyelitis Therapeutics Market Share by Application (2016-2027) Figure 55. Middle East & Africa Poliomyelitis Therapeutics Market Share by Country (2016-2027) Figure 56. Turkey Poliomyelitis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 57. Saudi Arabia Poliomyelitis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 58. UAE Poliomyelitis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 59. Sanofi Revenue Growth Rate in Poliomyelitis Therapeutics Business (2016-2021) Figure 60. GSK Revenue Growth Rate in Poliomyelitis Therapeutics Business (2016-2021) Figure 61. Bibcol Revenue Growth Rate in Poliomyelitis Therapeutics Business (2016-2021) Figure 62. Serum Institute Revenue Growth Rate in Poliomyelitis Therapeutics Business (2016-2021) Figure 63. Tiantan Biological Revenue Growth Rate in Poliomyelitis Therapeutics Business (2016-2021) Figure 64. IMBCA Revenue Growth Rate in Poliomyelitis Therapeutics Business (2016-2021) Figure 65. Panacea Biotec Revenue Growth Rate in Poliomyelitis Therapeutics Business (2016-2021) Figure 66. Bio-Med Revenue Growth Rate in Poliomyelitis Therapeutics Business (2016-2021) Figure 67. Halfkin Bio-Pharmaceuticals Revenue Growth Rate in Poliomyelitis Therapeutics Business (2016-2021) Figure 68. Merck Revenue Growth Rate in Poliomyelitis Therapeutics Business (2016-2021) Figure 69. CSL Revenue Growth Rate in Poliomyelitis Therapeutics Business (2016-2021) Figure 70. Astellas Pharma Revenue Growth Rate in Poliomyelitis Therapeutics Business (2016-2021) Figure 71. Emergent BioSolutions Revenue Growth Rate in Poliomyelitis Therapeutics Business (2016-2021) Figure 72. Johnson & Johnson Revenue Growth Rate in Poliomyelitis Therapeutics Business (2016-2021) Figure 73. Pfizer Revenue Growth Rate in Poliomyelitis Therapeutics Business (2016-2021) Figure 74. MedImmune Revenue Growth Rate in Poliomyelitis Therapeutics Business (2016-2021) Figure 75. Bottom-up and Top-down Approaches for This Report Figure 76. Data Triangulation Figure 77. Key Executives Interviewed

Sanofi GSK Bibcol Serum Institute Tiantan Biological IMBCA Panacea Biotec Bio-Med Halfkin Bio-Pharmaceuticals Merck CSL Astellas Pharma Emergent BioSolutions Johnson & Johnson Pfizer MedImmune